Bioactive Compounds
-
C8763 AUNP-12Summary: A novel immune checkpoint modulator, a competitive antagonist targeting the PD-1/PD-L1 pathway. -
C8764 CGRP 8-37 (rat) acetateSummary: A CGRP receptor antagonist -
C8765 TAS-102Summary: An oral nucleoside antitumor combination consisting of Trifluridine and Tipiracil -
A9949 Epinecidin-1Summary: An antimicrobial peptide -
BA7012 ResiniferatoxinSummary: TRPV1 agonist -
BA8213 YonkenafilSummary: Yonkenafil (Tunodafil) is a novel phosphodiesterase 5 inhibitor that is effective in reducing cerebral infarction, neurological deficits, edema, and neuronal damage in the infarcted area. -
BA4816 ValemetostatSummary: An EZH1/2 inhibitor -
C8766 Poloxamer 407 (F127)Summary: A non-ionic triblock copolymer surfactant that can induce an acute hyperlipidemia mouse model under high-dose conditions. -
C8767 (±)-Epibatidine dihydrochlorideSummary: A highly selective nicotinic acetylcholine receptor (nAChR) agonist -
C8808 DMBSummary: An orally active GLP-1R agonist

